Marcelle Ruth Cancer Centre & Specialist Hospital

What Marcelle Ruth Cancer Centre & Specialist Hospital does

Marcelle Ruth Cancer Centre & Specialist Hospital is a privately held, for-profit multi-specialty hospital headquartered on Victoria Island, Lagos, Nigeria. Founded in 2020 by UK-trained haemato-oncologist Dr. Modupe Elebute-Odunsi, the facility was the first comprehensive cancer centre of its kind in Nigeria and West Africa and has served over 5,000 patients since opening. It operates a one-stop integrated model that consolidates screening, diagnostics, surgery, chemotherapy, radiotherapy, inpatient care, and ancillary services such as nutrition, physiotherapy, counselling, and home care on a single campus, with fifteen private en-suite rooms, two operating theatres, and an eight-bed chemotherapy suite.

The centre's technology backbone centres on West Africa's first Varian TrueBeam linear accelerator with brachytherapy, alongside GE Healthcare imaging equipment (CT, 3D mammography, 3D ultrasound, digital X-ray), an on-site sterile chemotherapy pharmacy, and partnerships with Roche and Pfizer for pharmaceuticals. It is NNRA-accredited for radiotherapy, NDPA-compliant for data protection, and in 2024 became the first private hospital in Nigeria accredited by the National Postgraduate Medical College for residency training in Clinical and Radiation Oncology in partnership with Lagos University Teaching Hospital. The centre also runs a Research & Development department with Phase II-IV clinical trial accreditation and a dedicated genomic studies programme.

Revenue is generated across seven streams: medical consultation fees, diagnostic services, cancer treatment (chemotherapy, radiotherapy, immunotherapy, surgery), three-tier screening packages (Concierge Swift, Standard, Plus), corporate retainer subscriptions, insurance billing through 15+ providers including Aetna, Allianz, BUPA, and Cigna, and home care services. Distribution is sales-led through direct hospital visits, appointments via phone, WhatsApp, and web, insurance claims, corporate retainer agreements, and GP referrals; marketing relies on community outreach, the CEO's public speaking engagements, an annual cancer walk, and patient testimonials. The facility is founder-owned with no disclosed institutional investors and serves primarily individual cancer patients, preventive healthcare seekers, employer-sponsored groups, and insured patients across Nigeria.

Name

Marcelle Ruth Cancer Centre & Specialist Hospital

Legal name

Marcelle Ruth Cancer Centre Limited

Website

https://marcelleruth.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

Marcelle Ruth Cancer Centre & Specialist Hospital is a privately held, multi-specialty cancer hospital in Lagos, Nigeria, founded in 2020 as the first comprehensive cancer centre in West Africa. It provides integrated screening, diagnostics, surgery, chemotherapy, and radiotherapy — anchored by West Africa's first Varian TrueBeam linear accelerator — to individual patients, corporate clients, and insured populations across Nigeria.

Ownership category

akta.pro rank

Product category

Oncology and Specialist Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Medical Laboratories (621511), Diagnostic Imaging Centers (621512), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-Medical Laboratories (8071), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Digestive Oncology (GI Cancer Care) (HLAKAEAF)

Keywords

• Oncology treatment services
• Cancer diagnostic imaging
• Radiotherapy services
• Specialist hospital care
• Preventive health screening

Headquarters

HQ city

Lagos

HQ country

Nigeria

HQ region

Africa

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Medical Consultation Fees: Revenue from specialist consultations across oncology, haematology, internal medicine, and other specialties.
2. Diagnostic Services: Revenue from imaging services (CT, mammogram, X-ray, ultrasound), laboratory tests, and biopsies.
3. Cancer Treatment: Revenue from chemotherapy, radiotherapy, immunotherapy, and surgical procedures. Treatment plans tailored to individual patients with itemized costs.
4. Screening Packages: Three-tiered screening packages (Concierge Swift, Standard, Plus) providing preventive health assessments.
5. Corporate Retainer: Annual or monthly fees from employer corporate health plans for employee healthcare access.
6. Insurance Billing: Revenue from insurance providers covering patient treatment costs based on coverage levels.
7. Home Care Services: Revenue from at-home chemotherapy delivery, nursing care, and end-of-life care services.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Marcelle Ruth Cancer Centre & Specialist Hospital provides integrated cancer care from screening and diagnosis through treatment and ongoing support, delivered at a single site in Lagos, Nigeria. Its offerings span cancer screening packages, advanced diagnostics (CT, 3D mammography, ultrasound, biopsy), and treatment modalities including chemotherapy, radiotherapy (TrueBeam linear accelerator and brachytherapy), immunotherapy, and surgery, alongside specialist services in haematology, internal medicine, interventional radiology, dermatology, ophthalmology, and sickle cell disease.

Product overview

Marcelle Ruth Cancer Centre & Specialist Hospital operates as a comprehensive one-stop healthcare facility in Lagos, Nigeria, providing integrated cancer care and specialist medical services. The core product portfolio centers on Cancer Screening Services (Concierge Swift, Standard, and Plus packages), Cancer Diagnostic Services (digital X-ray, 3D ultrasound, 3D mammography, CT, biopsies, blood tests), and Cancer Treatment Services (surgery, chemotherapy suite, radiotherapy centre with TrueBeam linear accelerator, immunotherapy). These are supported by specialist treatments including haematology, laparoscopic surgery, internal medicine, interventional radiology, dermatology, ophthalmology, and sickle cell services. Support services include counselling, nutrition, physiotherapy, home care, pharmacy, laboratory, imaging centre, and 15 private inpatient rooms. Add-on offerings comprise the MRCare Health Insurance Plan (in partnership with Leadway Health), Research & Development Department (clinical trials and genomic research), and Oncology Residency Program (accredited in partnership with LUTH). The hospital leverages technology partnerships with GE Healthcare, Varian, Roche, Pfizer, ISN Medical, and Brandon Medical for equipment and supplies.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Screening Services
• Cancer Diagnostic Services
• Cancer Treatment Services
• Surgery Services
• Chemotherapy Suite
• Radiotherapy Centre
• Oncology Services
• Haematology Services
• Laparoscopic Surgery
• Internal Medicine Services
• Interventional Radiology
• Dermatology Services
• Ophthalmology Services
• Sickle Cell Services
• Counselling Services
• Nutrition Services
• Physiotherapy Services
• Home Care Services
• Pharmacy Services
• Laboratory Services
• Imaging Centre
• Inpatient Rooms
• MRCare Health Insurance Plan
• Women's Wellness Clinics
• Oncology Residency Program
• Research & Development Department

Quantifiable outcome

• Serving over 5,000 patients since opening
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• Katchey Company LimitedminorStrategic or Co-development Partner · 25 January 2025Collaboration discussions on histopathology, molecular, and genetic testing. Katchey expressed commitment to building cancer diagnostics ecosystem in Nigeria with advanced molecular and analytical tools.
• University of Maryland School of MedicineminorStrategic or Co-development Partner · 13 August 2024Visit by Prof. Mark Gladwin (Dean) and Prof. Taofeek Owonikoko (Head of Oncology). Discussions on potential collaborations for research, training, and capacity building. Prof. Owonikoko previously led researchers at UPMC.
• National Institute for Cancer Research and Treatment (NICRAT)coreStrategic or Co-development Partner · 12 August 2024Hosting Prof. Usman Aliyu Malami (DG) and Dr. Usman Waziri. NICRAT leads national cancer control efforts including MoU with FLAC and Roche for cancer treatment, research, and advocacy.
• Lagos University Teaching Hospital (LUTH)coreStrategic or Co-development Partner · 3 June 2024Oncology residency training partnership accredited by National Postgraduate Medical College. Enables joint training of radiation and clinical oncology specialists. Prof. Wasiu Lanre Adeyemo (CMD LUTH) expressed confidence in public-private partnerships for healthcare improvement.
• Leadway HealthcoreStrategic or Co-development Partner · 1 January 2024First-of-its-kind comprehensive health insurance partnership launched in 2024, focusing on preventive care, significant cancer coverage, and access to 2000+ partner hospitals nationwide. Led by Dr Olatokunbo Alli with Chairman Bolaji Odunsi driving the initiative.
• Varian Medical SystemscoreTechnology or IntegrationProvider of TrueBeam linear accelerator radiotherapy equipment - West Africa's first installation. Key technology partnership for precision cancer treatment.
• GE HealthcarecoreTechnology or IntegrationTechnology partnership for imaging equipment including CT, mammogram, ultrasound, and X-ray machines.
• RochecoreTechnology or IntegrationPharmaceutical technology partnership. Roche also involved in clinical trials partnership for triple-negative breast cancer research.
• Institute of Human Virology Nigeria (IHVN)minorStrategic or Co-development PartnerResearch collaboration with Dr. Patrick Dakum (CEO), Prof. Alashe'le Abimiku, and team for health research and biosecurity initiatives.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Lagoon Hospitals: Lagos private hospital group where multiple Marcelle Ruth executives (including the Director of Operations and Client Services Manager) previously worked. Competes for the same private-pay tertiary care market in Lagos.
• Lakeshore Cancer Centre: India-based dedicated oncology hospital with comprehensive radiotherapy, chemotherapy and surgical oncology. Closest international comparable for a single-site, oncology-only specialist hospital model serving regional populations.
• NSIA-LUTH Cancer Centre: Public-sector comprehensive cancer centre co-located at Lagos University Teaching Hospital, offering radiotherapy, chemotherapy and surgical oncology in the same Lagos market as Marcelle Ruth. Direct competitor for complex cancer cases and high-end patients.
• Reddington Hospital: Lagos private multi-specialist hospital with diagnostic and specialist services, where incoming CMO Dr. Misbah Oleolo previously served as Medical Director. Comparable private tertiary care positioning in the same Lagos market.
• Euracare Multi-Specialist Hospital: Lagos-based advanced multi-specialist hospital with diagnostic imaging, oncology, and surgical services serving similar affluent Lagos and expatriate patients. Comparable private-pay tertiary care model in the same geography.

Broad incumbents

• HCA Healthcare UK: Large private hospital operator in the UK where Marcelle Ruth's founder trained and worked. Comparable private-pay specialist model with established clinical pathways for complex oncology cases.
• Apollo Hospitals: Large Indian hospital network with dedicated oncology centres, established medical tourism flows from Africa, and comparable comprehensive cancer service lines. Represents the regional incumbent competing for outbound Nigerian oncology patients.
• Cleveland Clinic: Global multi-specialty health system with a comprehensive Taussig Cancer Institute. Represents the gold-standard integrated cancer centre model Marcelle Ruth aspires to emulate, with comparable multidisciplinary one-site care.
• The Royal Marsden NHS Foundation Trust: World-leading UK specialist cancer hospital where Marcelle Ruth's founder completed postgraduate training. Closest clinical and academic benchmark for a dedicated comprehensive cancer centre model.

Regional players

• Aga Khan University Hospital: East Africa's leading private tertiary hospital in Nairobi with oncology and diagnostic services. Comparable mission-driven private academic hospital serving regional patients who might otherwise seek care abroad.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/marcelle-ruth-cancer-centre
• Instagraminstagram.com/mrcc_researchanddevelopment
• Xx.com/mrccsh
• Facebookfacebook.com/MarcelleRuthCancerCentreandSpecialistHospital

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Marcelle Ruth Cancer Centre & Specialist Hospital